BioAim Scientific (Kanada)
The Bioaim Human EGF ELISA kit is a solid phase sandwich ELISA (enzyme-linked immunosorbent assay) for the quantitative measurement of EGF in human serum and plasma. An antibody specific for human EGF was coated on a 96-well plate. Standards and samples are added to the wells and any EGF present binds to the immobilized antibody. The wells are washed and biotinylated anti-human EGF antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is added to the wells. The wells are again washed and TMB substrate solution is added, which produces a blue color in direct proportion to the amount of EGF present in the initial sample. The Stop Solution changes the color from blue to yellow, and the microwell absorbances are read at 450 nm.Research Area Cancer Biomarker; Cell adhesion; Inflammation;
epidermal growth factor ( EGF ) Background: Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds. EGF is expressed as a transmembrane protein that is proteolytically cleaved to generate soluble forms. It signals through EGF R/ErbB1 which heterodimerizes with ErbB2, ErbB3, or ErbB4 and can also associate with PDGF R beta and HGF R/c-MET. During development, EGF regulates thymocyte differentiation, neuroglia production, and adipocyte maturation. In the adult, EGF plays a role in mammary gland lactogenesis, fibroblast mitosis, dissociation of the extracellular matrix, and cell migration.
< 1 pg/ml
Serum, plasma, Cell culture supernatant
|Sensitivity||< 1 pg/ml|
|Antigen Name||epidermal growth factor|
|Detection Range||0.82-200 pg/ml|